Aetna Reports Fourth-Quarter And Full-Year 2012 Results
Aetna (NYSE: AET) today announced fourth-quarter 2012 operating earnings (1) of $317.0 million, or $.94 per share. Full-year 2012 operating earnings (1) were $1.77 billion, or $5.13 per share. Net income for the fourth quarter of 2012 was $190.1 million, or $.56 per share, and includes $.44 per share of charges for other items, primarily a litigation-related settlement, offset by $.06 per share of net realized capital gains. Full-year net income was $1.66 billion, or $4.81 per share.
| Fourth-Quarter Financial Results at a Glance | ||||||||||||
| (Millions, except per share results) | 2012 | 2011 | Change | |||||||||
| Revenue (2) | $ | 8,955.0 | $ | 8,544.1 | 5 | % | ||||||
| Operating earnings (1) | 317.0 | 354.3 | (11 | )% | ||||||||
| Net income | 190.1 | 372.6 | (49 | )% | ||||||||
| Per share results: | ||||||||||||
| Operating earnings (1) | $ | .94 | $ | .97 | (3 | )% | ||||||
| Net income | .56 | 1.02 | (45 | )% | ||||||||
| Weighted average common shares - diluted | 338.5 | 365.8 | ||||||||||
| Full-Year Financial Results at a Glance | ||||||||||||
| (Millions, except per share results) | 2012 | 2011 | Change | |||||||||
| Revenue (2) | $ | 35,544.8 | $ | 33,611.9 | 6 | % | ||||||
| Operating earnings (1) | 1,769.6 | 1,965.7 | (10 | )% | ||||||||
| Net income | 1,657.9 | 1,985.7 | (17 | )% | ||||||||
| Per share results: | ||||||||||||
| Operating earnings (1) | $ | 5.13 | $ | 5.17 | (1 | )% | ||||||
| Net income | 4.81 | 5.22 | (8 | )% | ||||||||
| Weighted average common shares - diluted | 345.0 | 380.2 | ||||||||||
“Aetna's solid fourth-quarter performance caps off an important year for the company. In 2012 we demonstrated the power of our diversified portfolio, advanced our mission to transform the health care marketplace and agreed to acquire Coventry Health Care, which will greatly enhance our long-term strategy,” said Mark T. Bertolini, Aetna chairman, CEO and president. “We are positioned well for 2013, with new commercial contract wins and a successful Medicare selling season across our entire portfolio of Medicare products.
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
